Asante Capital Solutions – Q1 2024 Newsletter
Our analysis of the Q1 fundraising landscape shows an improving picture: M&A activity is expected to return in H2 2024, with a significant majority of investors we polled anticipating receiving greater distributions in 2024 compared to the previous year.
Asante Capital Group Announces Laura Leyland’s Promotion to Partner
We are pleased to announce Laura Leyland has been promoted to Partner at Asante Capital! In her 10+ years spent at the firm, Laura has led remarkable achievements in mid-market private equity fundraisings across growth, buyout, and real assets funds.
Winner at The Real Deals Private Equity Awards
We are proud to announce that Asante Capital has won ‘Specialist Fund Adviser of the Year Award’ at The Real Deals Private Equity Awards 2024! This award is a credit to the remarkable work of our entire Asante team and the invaluable support of our global partners.
Asante Capital congratulates Maguar Capital on the successful closing of Fund 2 at a hard cap of EUR 306 million
We are pleased to share that Maguar, a Munich-based investor group focused on B2B software companies in the DACH region, has closed Maguar 2 at EUR 306 million, significantly exceeding the EUR 250 million target.
Asante Capital Solutions – Q4 2023 Newsletter
Amid heightened economic volatility in 2023, Asante saw fundraising headwinds begin to slowly subside. As we reflect on another strong year of progress, our team has analyzed some of the key trends that dominated 2023.
Asante Capital congratulates partner HighLight Capital (HLC) on the final closing of its flagship HLC USD Fund IV at US$550 million
We are delighted to share that HighLight Capital (HLC), a private equity firm focusing on venture and growth investments across healthcare and consumer health sectors in China, held the final close of its flagship HLC USD Fund IV at US$550 million.
Asante Capital Group Celebrates 2023 Achievements, Extends Track Record of Successful Fundraises and Grows Global Team
As we enter 2024, Asante is pleased to announce another exceptional year, extending our track record of successful fundraising, strengthening our global presence and offerings, and facilitating expert discussions throughout 2023.
Asante Capital Solutions – Q3 2023 Newsletter
Asante teamed up with some of our partners to analyze these changes as part of our Summer Series round table discussion. Key themes and trends addressed in the series include evolving GP-LP dynamics, creative capital raising initiatives, secondaries, and more.
Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million
We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.
Asante Capital congratulates its partner Norvestor on closing Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion
We are delighted to share that Norvestor, a leading private equity firm in the Nordics, has closed Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion, exceeding its €1.25 billion target, despite a challenging fundraising environment.